安徽威尔曼制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
98
NMPA:98
Drug Approvals
Ceftizoxime Sodium for Injection
- Product Name
- 注射用头孢唑肟钠
- Approval Number
- 国药准字H20253914
- Approval Date
- Apr 15, 2025
NMPA
Ceftizoxime Sodium for Injection
- Product Name
- 注射用头孢唑肟钠
- Approval Number
- 国药准字H20253913
- Approval Date
- Apr 15, 2025
NMPA
Ceftazidime for Injection
- Product Name
- 注射用头孢他啶
- Approval Number
- 国药准字H20258064
- Approval Date
- Apr 10, 2025
NMPA
Cefoperazone Sodium and Sulbactam Sodium for Injection
- Product Name
- 注射用头孢哌酮钠舒巴坦钠
- Approval Number
- 国药准字H20258056
- Approval Date
- Apr 7, 2025
NMPA
Cefoperazone Sodium and Sulbactam Sodium for Injection
- Product Name
- 注射用头孢哌酮钠舒巴坦钠
- Approval Number
- 国药准字H20065013
- Approval Date
- Mar 23, 2025
NMPA
Cefotaxime Sodium for Injection
- Product Name
- 注射用头孢噻肟钠
- Approval Number
- 国药准字H20237184
- Approval Date
- Dec 26, 2023
NMPA
Tetracaine Hydrochloride for Injection
- Product Name
- 注射用盐酸丁卡因
- Approval Number
- 国药准字H20093220
- Approval Date
- Dec 20, 2023
NMPA
Vecuronium Bromide for Injection
- Product Name
- 注射用维库溴铵
- Approval Number
- 国药准字H20084539
- Approval Date
- Dec 20, 2023
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 10
- Next
Clinical Trials
No trials found
News
No news found